PAR 0.00% 23.0¢ paradigm biopharmaceuticals limited..

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-48

  1. 830 Posts.
    lightbulb Created with Sketch. 207
    Unless your name is Pfizer or Merck, we have now entered a dangerous time in the approval of new drugs, re-purposed or off label are getting smashed from pillar to post in this lunatic covid time.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.